arrow
P

Pasquale Persico

IRCCS Humanitas Research Hospital
H指数:16
被引数:944

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience

手术后接受vorasidenib的CNS 3级IDH突变型胶质瘤患者的驾驶选择和临床过程的原因: 试点经验

2026-01-280
PRE
A PHASE 1, FIRST-IN-HUMAN STUDY OF REGORAFENIB PLUS TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED, IDH WILDTYPE GLIOBLASTOMA: THE REGOMA-2 TRIAL

一项关于瑞戈非尼联合替莫唑胺,在有或无放疗情况下,用于新诊断的MGMT甲基化、IDH野生型胶质母细胞瘤患者的I期首个人类研究:REGOMA-2试验

2025-11-010
OAAI
A PHASE 1, FIRST-IN-HUMAN STUDY OF REGORAFENIB PLUS TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED, IDH WILDTYPE GLIOBLASTOMA: REGOMA-2 TRIAL

一项关于瑞戈非尼联合替莫唑胺,无论是否联用放疗,在 newly diagnosed MGMT methylated, IDH wildtype glioblastoma 患者中的首次人体研究的第1阶段:REGOMA-2试验

2025-10-010
OAAI
Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

免疫检查点抑制剂治疗患者中心脏不良事件的MRI研究:一项前瞻性队列研究

2025-03-180
OA
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram

使用新颖且外部验证的预后列线图,为下一代免疫治疗早期临床试验优化患者选择

2024-01-150
OAAI
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2023-01-1718
OAAI
Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas
2023-01-104
OAAI
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes
2021-11-132
OAAI
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study

11C蛋氨酸正电子发射断层扫描 (11CMETPET) 在新诊断的胶质母细胞瘤患者的手术和放射治疗计划中的作用参加II期临床研究

2021-05-2510
OAAI